Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2014

May 2, 2014

5262_dirs_2014-05-02_b36546d9-5800-4aef-bd2c-4dcaa8292a8c.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2465G

GlaxoSmithKline PLC

02 May 2014

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of Sir Andrew Witty, a Director, and his Connected Persons, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):

(a)  The transfer on 1 May 2014 by way of gift of 500 Ordinary Shares in the Company from Sir Andrew to each of his two children;

(b)  The sale on 1 May 2014 of 731 Ordinary Shares and the repurchase of 724 Ordinary Shares and transfer into an ISA at a price of 1629.0550p and 1629.4650p per share respectively; and

(c)  The exercise of options over 100,000 Ordinary Shares on 1 May 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and the sale of 100,000 Ordinary shares at a price of £16.385 per share on 1 May 2014.

The Company was advised of transaction (a) on 1 May and advised of transactions (b) and (c) on 2 May 2014.

This notification relates to transactions notified in accordance with paragraph 3.1.4R(1)(a) and(c) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

2 May 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQLLFBZEFXBBB